UBT251 Injection Phase II Clinical Study (CKD)

NCT07134335 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity &Amp; Overweight
Chronic Kidney Disease

Interventions

DRUG: UBT251
DRUG: UBT251
DRUG: UBT251

Sponsor

The United Bio-Technology (Hengqin) Co., Ltd.